BiotechTube
NuvoAir

NuvoAir

Stockholm, Sweden· Est.
nuvoair.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $39M

Overview

NuvoAir operates at the intersection of respiratory care, cardiology, and digital health, offering a comprehensive platform for remote patient monitoring and chronic disease management. The company employs a B2B2C business model, partnering with providers, health plans, and pharmaceutical companies to deliver value-based care. Clinical data cited by the company shows significant reductions in hospitalizations, readmissions, and total medical spend for enrolled patients. NuvoAir has expanded its offerings to include sleep care and a specialist-guided weight management program that includes GLP-1 medications.

RespiratoryCardiologySleep MedicineMetabolic Disease

Technology Platform

Integrated digital health platform combining FDA-cleared at-home monitoring devices, patient app, clinician dashboard for data aggregation/analytics, and 24/7 clinical support services for remote patient monitoring and chronic disease management.

Funding History

3
Total raised:$39M
Series B$25M
Series A$12M
Seed$2M

Opportunities

The global shift towards value-based care and remote patient monitoring creates a massive market for proven solutions that reduce hospitalizations.
Expansion into specialist-guided weight management, including GLP-1 medications, taps into a high-growth market and allows for cross-selling with core cardiopulmonary services.
Partnerships with health plans and pharmaceutical companies for data and trial services offer high-margin B2B revenue streams.

Risk Factors

Revenue is heavily dependent on complex and evolving US healthcare reimbursement policies for remote monitoring and value-based contracts.
The weight management space is intensely competitive, and scaling a hybrid tech/clinical service model operationally is challenging.
Continuous generation of robust clinical and economic evidence is required to maintain a competitive edge and secure large partnerships.

Competitive Landscape

NuvoAir competes in the digital chronic disease management space against large medtech/device companies (e.g., ResMed, Philips), standalone RPM software platforms, and other integrated care startups (e.g., Propeller Health, now part of ResMed, and Huma). In weight management, it faces competition from pure-play telehealth providers (e.g., Hims & Hers, Ro) and established healthcare systems. Its differentiation lies in its deep focus on complex cardiopulmonary conditions, integrated clinical service model, and payer relationships.

More companies in Sweden →